InvestorsHub Logo
Followers 37
Posts 2960
Boards Moderated 0
Alias Born 01/14/2003

Re: Martinko post# 265939

Tuesday, 04/14/2020 9:09:29 AM

Tuesday, April 14, 2020 9:09:29 AM

Post# of 425648
"I guess Amarin is able to produce some cheap version of brand Vascepa as a generic if that is the case...a with this version they can easily compete with other generics"

in addition, if amarin markets the first generic vascepa, amarin gets the vast majority of the generic vascepa market as well as what remains to the branded vascepa market. it's a method to continue getting practically all the revenues that vascepa generates in the US, both branded AND generic.

It's the ratio, baby ... the EPA/AA ratio!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News